HONOLULU--(BUSINESS WIRE)--Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced positive results for the phase 1 clinical trial of ACE-011 at The American Society for Bone and Mineral Research (ASBMR) 29th Annual Meeting held in Honolulu, Hawaii, USA, September 16 – 19, 2007. The oral presentation was titled, “A Single Dose of ACE-011 Is Associated with Increases in Bone Formation and Decreases in Bone Resorption Markers in Healthy, Postmenopausal Women,” and was presented this morning at the Hawaii Convention Center.
